STOCK TITAN

Gilead Sciences (GILD) Net Income by Year

GILD NASDAQ

Gilead Sciences Inc reported $8.5B in net income in fiscal year 2025. This represents an increase of 1672.9% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to a $3.9B net loss. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Gilead Sciences Inc has filed alongside them.

FY2025 annual
Net Income $8.5B
YoY +1672.9%
5Y CAGR +133.3%
10Y CAGR -7.3%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

GILD Net Income by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$3.9B$8.5B+1672.9%$480.0M-91.5%$5.7B+23.4%$4.6B-26.2%$6.2B+4961.0%$123.0M-97.7%$5.4B-1.3%$5.5B+17.9%$4.6B-65.7%$13.5B-25.4%$18.1B+49.6%$12.1B+293.5%$3.1B+18.6%$2.6B-7.5%$2.8B

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

GILD Net Income by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Net Income$2.4B-20.4%-$10.5B-635.5%$2.0B+53.7%$2.2B+22.4%$3.1B+143.6%$2.0B+21.4%$1.3Bn/m$1.8B+24.7%$1.3B-42.5%$1.6B+54.4%-$4.2B-512.9%$1.4B-12.8%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Gilead Sciences Inc financials

Frequently Asked Questions

Gilead Sciences Inc reported $8.5B in net income in fiscal year 2025.

Gilead Sciences Inc (GILD) net income rose by 1672.9% year over year, from $480.0M to $8.5B in fiscal year 2025.

Gilead Sciences Inc (GILD) reported a $3.9B net loss over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Gilead Sciences Inc (GILD) net income went from $2.8B in fiscal year 2011 to $8.5B in fiscal year 2025.

Gilead Sciences Inc (GILD) reported $2.4B in net income in Q3 2026. This represents a decrease of 20.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Gilead Sciences Inc (GILD) reported on that line in every period on record.